Ischemic stroke initiates a robust inflammatory response that starts in the intravascular compartment and involves rapid activation of brain resident cells. A key mechanism of this inflammatory response is the migration of circulating immune cells to the ischemic brain facilitated by chemokine release and increased endothelial adhesion molecule expression. Brain-invading leukocytes are well-known contributing to earlystage secondary ischemic injury, but their significance for the termination of inflammation and later brain repair has only recently been noticed.
Introduction
Cerebral stroke triggers a sustained inflammatory response that starts rapidly after cessation of the local blood flow and involves virtually all parts of the immune system. One important hallmark of this inflammatory response is a timed influx of immune cells to the brain which is driven by the activation of brain endothelial cells, substantial chemokine secretion and increased sympathetic outflow [1] [2] [3] . Inflammatory cell infiltration was previously considered deleterious in ischemic stroke, however, several treatment trials designed to indiscriminately block leukocyte egress to the brain failed to induce a measurable clinical benefit 4 . More recently, it became evident that monocyte-derived cells initially involved in progression of ischemic damage 5 might also play a pivotal role for resolution of inflammation and subsequent tissue repair 6 .
Thanks to the identification of phenotypic and functional heterogeneity among monocytes and macrophages, the knowledge on the role of mononuclear phagocytes in development and resolution of inflammation has significantly expanded. In mice, circulating monocytes can be classified into at least two functionally distinct subsets according to their surface expression of lymphocyte antigen 6 complex (Ly-6C) 7 . While Ly-6C high ´inflammatory monocytes´ were clearly shown to be essential for the control of bacterial infections 8 , their role in sterile injury is more controversial. In ischemic stroke, selective ablation of CCR2+ Ly-6C high monocytes resulted in hemorrhagic infarct transformation 6 . However, the same experimental approach improved acute disability after intracerebral hemorrhage 9 . Similarly, different subsets of T cells are believed to exert either detrimental 10 or protective actions 11 in ischemic brain injury, however, data is controversial 12, 13 and warrants further investigations.
Given this increasing complexity, it becomes clear that deeper knowledge on the roles of the diverse immune cells in ischemic injury and repair is crucial for translating experimental findings into therapies targeting post stroke inflammation.
Today, the most powerful tool for analyzing cellular immune responses is polychromatic flow cytometry. It allows the identification and quantification of various immune cell subsets at the site of inflammation without the need to bias the system by in vivo labeling or genetic manipulation
Dissociation of Cerebral Tissue into Single Cell Suspensions
1. Carefully remove brain stem and cerebellum with a clean razor blade. Use a clean razor blade to hemisect the brain and cut each hemisphere along the coronal plane into three pieces of roughly equal size. 2. Mince dissected tissue of each hemisphere through a 100 µm cell strainer using the plunger end of a 5 ml syringe. Continuously rinse the cell strainer with ice-cold HBSS (+Ca/Mg). Store homogenized samples on ice. 3. Centrifuge at 286 x g and 4° C for 5 min, carefully discard the supernatant. Resuspend the pellet in 1 ml of digestion buffer and transfer the suspension into a 2 ml tube. Incubate suspension under slow continuous rotation at 37 °C for 1 hr. 4. Sieve cell suspension through a 70 µm cell strainer and rinse thoroughly with 3 ml of washing buffer containing DNAse followed by 15 ml of DNAse-free washing buffer. Centrifuge at 286 x g and 18 °C for 5 min and discard the supernatant. Note: Note: The use of DNAse eliminates DNA mucus caused by cell lysis which might lead to cell aggregation compromising cell survival.
Density Gradient Centrifugation for Removal of Myelin and Cell Debris
1. Resuspend cell pellet in 5 ml of 25% density gradient medium and pipette the suspension to a 15 ml tube. Mix thoroughly by repeated and gentle pipetting avoiding bubble formation. Note: density gradient medium should be used at RT to prevent cell clumping. 2. Centrifuge at 521 x g and 18 °C for 20 min. Use lowest acceleration profile of the rotor and allow the rotor to stop without brake. Gently remove the tubes from the centrifuge without shaking. Carefully aspirate the myelin coat and the supernatant while preserving the cell pellet at the bottom of tube. Note: Make sure to remove the entire myelin coat as any leftover will impair flow cytometric analysis. 3. Resuspend the pellet in 10 ml of DNAse free washing buffer and pipette the suspension to a new 15 ml tube. Note:This washing step is crucial since sufficient removal of density gradient medium significantly contributes to the quantity and quality of the final cell sample. 4. Centrifuge again at 286 x g and 10 °C for 5 min and discard the supernatant. Resuspend cells in 100 µl of cold washing buffer and determine cell counts and viability by trypan blue exclusion in a hemocytometer. Store samples at 4 °C and further process them quickly.
Antibody Staining for Flow Cytometric Analysis
1. Prior to antibody labeling, incubate the cell suspension at 4 °C for 10 min with anti-murine CD16/CD32 FC-Receptor blocking reagent (final concentration of 2.5 µg/ml, dilution factor 1:200) to prevent unspecific binding. 2. Add fluorophore-conjugated primary antibodies at the appropriate concentration (as indicated in Table 1 ) to the cell suspension and incubate at 4 °C for 20 min in the dark. Note: Control samples are not stained with primary antibodies, but otherwise treated the same. 
Flow Cytometric Acquisition
Note: To analyze the proposed antibody panel, the appropriate cytometer has to be equipped with a blue (488 nm), red (635 nm) and violet (405 nm) laser and filters for FITC, PE, PerCP Cy5.5, PECy7, APC-Cy7 and AmCyan. The composition of the brain infiltrate 24 hr after MCAO was determined by flow cytometric analysis. Figure 1 illustrates the gating strategy schematically (A) and in a representative stroke animal (B). Brain-infiltrating leukocytes were defined as CD45 high cells that can be differentiated from CD45 int microglia. Within the CD45 high population, polymorphonuclear neutrophils (PMN) were identified by Ly-6G expression, while T lymphocytes were delineated as CD45 high CD3+ cells. The remaining CD45 high cells were then distinguished by CD19 (B lymphocytes) and
CD11b expression. The CD11b+ fraction was further subcategorized into Ly-6C high `inflammatory monocytes` and a Ly-6C low population that encompasses monocytes, dendritic cells (DC) and macrophages.
In the acute stage of stroke, myeloid immune cells dominate the brain infiltrate 3, 20 . Neutrophils enter the brain rapidly after vessel occlusion and promote the extravasation of inflammatory monocytes 21 . Figure 2A displays the percentage increase of Ly6-G+ neutrophils in the ischemic hemisphere 24 hr after MCAO compared to the contralateral hemisphere and sham surgery. By contrast, the proportion of CD3+ T cells in the ischemic hemisphere is (relatively) lower than in the healthy brain. Within the CD11b+ population, brain ischemia shifts the balance towards a strong preponderance of Ly-6C high inflammatory monocytes (Figure 2B) .
In addition to relative distributions, counting tubes were used to determine absolute numbers of immune cell subsets in samples on the basis of CD45 positive events (Figure 3) . Counting tubes contain a lyophilized pellet which releases a known number of fluorescent beads. The absolute number of positive cells in the sample can be determined by relating cellular events to bead events. To calculate the number of CD45 high leukocytes per hemisphere the following equation was used: CD45 high cells per hemisphere = (CD45 high events x total counting beads/ sample bead events) x (total suspension volume (100 µl)/sample volume (10 µl)). 24 hr after MCAO, total leukocyte counts in the infarct hemisphere were significantly increased as compared to the contralateral hemisphere and sham surgery (Figure 3D , one-way ANOVA, p = 0.0004). Counts of the distinct immune cell subsets (PMN, T-cells, B-cells, Ly-6C high and Ly-6C low monocytes) can be easily computed by multiplying their relative frequency with the total CD45 high leukocyte number of the respective sample. 
Discussion
Here, we describe a simple and effective method for the isolation of leukocytes from the murine brain after experimental stroke. The approach reliably yields highly reproducible cell counts per brain hemisphere allowing to measure different flow panels in one biological replicate.
Apparently, an incomplete removal of blood including immune cells will result in a distorted view on the actual amount of inflammatory cells that entered the ischemic brain. Thus, when using this protocol pay particular attention to thorough transcardial perfusion to prevent contamination of infiltrated immune cells with non-inflammatory circulating leukocytes. From experience, the usage of blunt needles for left ventricle puncture reduces the risk for injury of the interventricular septum which would bypass perfusion of the systemic circulation. Emergence of perfusion fluid from the nostrils is a sign that the perfusion pressureis too high, thus, avoid flow rates >10 ml/min. Pale to white color of the brain tissue indicates good perfusion while pinkish color is a sign of poor perfusion.
. For enzymatic digestion Liberase TL is recommended which is a mixture of highly purified collagenase I and II that contains low concentrations of the neutral protease thermolysin. The direct comparison with previously described isolation protocols 14, 22, 23 revealed significantly higher recovery of viable cells by Liberase TL treatment (K.M. unpublished data). Compared to collagenase which is frequently used for the isolation of immune cells from the brain, Liberase TL contains negligible levels of endotoxin. This is of special importance if cells are sorted for downstream analysis because high levels of endotoxin might change the activation state of immune cells 24 and severely impair cell culture outcomes 25 . Another drawback of traditional collagenase is significant lot-to-lot differences in the enzyme activities which jeopardizes reproducibility of results and requires determination of the working concentration for each lot 26 .
In the adult brain, myelin removal by density gradient centrifugation is an indispensable step for downstream applications such as flow cytometry or further studies on gene or protein expression. One major advantage of the protocol is the single-layer density procedure which does not require time-consuming preparation of gradients. Moreover, the separation protocol produces reliable results even when performed by rather inexperienced experimenters. It is devoid of layered gradients with densities close to one another that are difficult to pipette without disturbing the interface in between.
Based on the expression of the surface marker CD45, the protocol yields three major cell categories in the ischemic brain. The vast majority of cells belong to a CD45 negative population that is composed of neuronal cells, astroglia, ependymal and endothelial cells. Their abundant presence is attributed to the single-layer density gradient which primarily aims at efficient myelin and debris removal. Additionally, a CD45 int population representing resident microglia 27 can be differentiated from a CD45 high population that primarily contains infiltrating hematogenous leukocytes. However, it should be noted that activated microglia may adopt the phenotype and function of blood-born myeloid cells. Thus, only applying sophisticated techniques such as parabiosis 28 , bone marrow chimeras 29 or fate mapping analysis 30 allow a clear-cut distinction between those two populations during inflammation.
Data analysis in flow cytometry is often limited to the percentage distribution of specific cell populations. However, when comparing the infarct hemisphere to non-infarcted brain tissue this information can be misleading because it does not consider total brain leukocyte counts which are changed by ischemic injury. Thus, to draw a full picture on the magnitude and phenotype of inflammatory infiltrates after stroke relative distribution of immune cell subsets should be complemented by absolute cell numbers. When using microbeads as described in this protocol, pipetting of a precise sample volume is absolutely mandatory to obtain reliable results. Moreover, reverse pipetting is strongly recommended to avoid foam formation in the counting tube. Arising air bubbles will reduce the expected volume of microbeads and hence lead to an overestimation of absolute CD45 high leukocyte counts in the sample.
In summary, this protocol provides an easy and reliable approach to isolate immune cells from the brain. It may serve as a valuable tool to dissect the complexity of the inflammatory response to ischemic stroke. Future applications include investigations on the time-dependent role of monocyte subsets in propagation and resolution of ischemic brain inflammation. Similarly, the role of the adaptive immune system after stroke is poorly understood. Flow cytometric analysis of T cell subpopulations identified by the expression of subset-specific transcription factors or cytokines in situ might help to clarify their impact on long-term recovery after stroke and thus open promising avenues for the development of new treatment approaches.
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